142 related articles for article (PubMed ID: 23665075)
1. Differential regulation of the glutamate transporter variants GLT-1a and GLT-1b in the cortex and spinal cord of transgenic rats expressing hSOD1(G93A).
Dumont AO; Hermans E; Goursaud S
Neurochem Int; 2013 Aug; 63(2):61-8. PubMed ID: 23665075
[TBL] [Abstract][Full Text] [Related]
2. Distinct expression and regulation of the glutamate transporter isoforms GLT-1a and GLT-1b in cultured astrocytes from a rat model of amyotrophic lateral sclerosis (hSOD1G93A).
Goursaud S; Maloteaux JM; Hermans E
Neurochem Int; 2009; 55(1-3):28-34. PubMed ID: 19428804
[TBL] [Abstract][Full Text] [Related]
3. GLT-1 glutamate transporter levels are unchanged in mice expressing G93A human mutant SOD1.
Deitch JS; Alexander GM; Del Valle L; Heiman-Patterson TD
J Neurol Sci; 2002 Jan; 193(2):117-26. PubMed ID: 11790392
[TBL] [Abstract][Full Text] [Related]
4. Impaired spinal cord glutamate transport capacity and reduced sensitivity to riluzole in a transgenic superoxide dismutase mutant rat model of amyotrophic lateral sclerosis.
Dunlop J; Beal McIlvain H; She Y; Howland DS
J Neurosci; 2003 Mar; 23(5):1688-96. PubMed ID: 12629173
[TBL] [Abstract][Full Text] [Related]
5. The VPAC2 agonist peptide histidine isoleucine (PHI) up-regulates glutamate transport in the corpus callosum of a rat model of amyotrophic lateral sclerosis (hSOD1G93A) by inhibiting caspase-3 mediated inactivation of GLT-1a.
Goursaud S; Focant MC; Berger JV; Nizet Y; Maloteaux JM; Hermans E
FASEB J; 2011 Oct; 25(10):3674-86. PubMed ID: 21730107
[TBL] [Abstract][Full Text] [Related]
6. Transgenic SOD1 G93A mice develop reduced GLT-1 in spinal cord without alterations in cerebrospinal fluid glutamate levels.
Bendotti C; Tortarolo M; Suchak SK; Calvaresi N; Carvelli L; Bastone A; Rizzi M; Rattray M; Mennini T
J Neurochem; 2001 Nov; 79(4):737-46. PubMed ID: 11723166
[TBL] [Abstract][Full Text] [Related]
7. Differential regulation of glutamate transporter subtypes by pro-inflammatory cytokine TNF-α in cortical astrocytes from a rat model of amyotrophic lateral sclerosis.
Dumont AO; Goursaud S; Desmet N; Hermans E
PLoS One; 2014; 9(5):e97649. PubMed ID: 24836816
[TBL] [Abstract][Full Text] [Related]
8. Increased internalisation and degradation of GLT-1 glial glutamate transporter in a cell model for familial amyotrophic lateral sclerosis (ALS).
Vanoni C; Massari S; Losa M; Carrega P; Perego C; Conforti L; Pietrini G
J Cell Sci; 2004 Oct; 117(Pt 22):5417-26. PubMed ID: 15466883
[TBL] [Abstract][Full Text] [Related]
9. Loss of metabotropic glutamate receptor-mediated regulation of glutamate transport in chemically activated astrocytes in a rat model of amyotrophic lateral sclerosis.
Vermeiren C; Hemptinne I; Vanhoutte N; Tilleux S; Maloteaux JM; Hermans E
J Neurochem; 2006 Feb; 96(3):719-31. PubMed ID: 16371010
[TBL] [Abstract][Full Text] [Related]
10. Expression of SOD1 G93A or wild-type SOD1 in primary cultures of astrocytes down-regulates the glutamate transporter GLT-1: lack of involvement of oxidative stress.
Tortarolo M; Crossthwaite AJ; Conforti L; Spencer JP; Williams RJ; Bendotti C; Rattray M
J Neurochem; 2004 Jan; 88(2):481-93. PubMed ID: 14690536
[TBL] [Abstract][Full Text] [Related]
11. Differential involvement of vesicular and glial glutamate transporters around spinal α-motoneurons in the pathogenesis of SOD1
Ohgomori T; Yamasaki R; Takeuchi H; Kadomatsu K; Kira JI; Jinno S
Neuroscience; 2017 Jul; 356():114-124. PubMed ID: 28526579
[TBL] [Abstract][Full Text] [Related]
12. PICK1 expression in reactive astrocytes within the spinal cord of amyotrophic lateral sclerosis (ALS) rats.
Focant MC; Goursaud S; Boucherie C; Dumont AO; Hermans E
Neuropathol Appl Neurobiol; 2013 Apr; 39(3):231-42. PubMed ID: 22624977
[TBL] [Abstract][Full Text] [Related]
13. Knocking down metabotropic glutamate receptor 1 improves survival and disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
Milanese M; Giribaldi F; Melone M; Bonifacino T; Musante I; Carminati E; Rossi PI; Vergani L; Voci A; Conti F; Puliti A; Bonanno G
Neurobiol Dis; 2014 Apr; 64():48-59. PubMed ID: 24361555
[TBL] [Abstract][Full Text] [Related]
14. Decreased GLT-1 and increased SOD1 and HO-1 expression in astrocytes contribute to lumbar spinal cord vulnerability of SOD1-G93A transgenic mice.
Guo Y; Duan W; Li Z; Huang J; Yin Y; Zhang K; Wang Q; Zhang Z; Li C
FEBS Lett; 2010 Apr; 584(8):1615-22. PubMed ID: 20303959
[TBL] [Abstract][Full Text] [Related]
15. Decrease in glial glutamate transporter variants and excitatory amino acid receptor down-regulation in a murine model of ALS-PDC.
Wilson JM; Khabazian I; Pow DV; Craig UK; Shaw CA
Neuromolecular Med; 2003; 3(2):105-18. PubMed ID: 12728193
[TBL] [Abstract][Full Text] [Related]
16. The anti-inflammatory peptide stearyl-norleucine-VIP delays disease onset and extends survival in a rat model of inherited amyotrophic lateral sclerosis.
Goursaud S; Schäfer S; Dumont AO; Vergouts M; Gallo A; Desmet N; Deumens R; Hermans E
Exp Neurol; 2015 Jan; 263():91-101. PubMed ID: 25311268
[TBL] [Abstract][Full Text] [Related]
17. Early loss of the glutamate transporter splice-variant GLT-1v in rat cerebral cortex following lateral fluid-percussion injury.
Yi JH; Pow DV; Hazell AS
Glia; 2005 Jan; 49(1):121-33. PubMed ID: 15390098
[TBL] [Abstract][Full Text] [Related]
18. Focal loss of the glutamate transporter EAAT2 in a transgenic rat model of SOD1 mutant-mediated amyotrophic lateral sclerosis (ALS).
Howland DS; Liu J; She Y; Goad B; Maragakis NJ; Kim B; Erickson J; Kulik J; DeVito L; Psaltis G; DeGennaro LJ; Cleveland DW; Rothstein JD
Proc Natl Acad Sci U S A; 2002 Feb; 99(3):1604-9. PubMed ID: 11818550
[TBL] [Abstract][Full Text] [Related]
19. GLT1 overexpression in SOD1(G93A) mouse cervical spinal cord does not preserve diaphragm function or extend disease.
Li K; Hala TJ; Seetharam S; Poulsen DJ; Wright MC; Lepore AC
Neurobiol Dis; 2015 Jun; 78():12-23. PubMed ID: 25818008
[TBL] [Abstract][Full Text] [Related]
20. Alternative splicing of the 5'-sequences of the mouse EAAT2 glutamate transporter and expression in a transgenic model for amyotrophic lateral sclerosis.
Münch C; Ebstein M; Seefried U; Zhu B; Stamm S; Landwehrmeyer GB; Ludolph AC; Schwalenstöcker B; Meyer T
J Neurochem; 2002 Aug; 82(3):594-603. PubMed ID: 12153483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
